58482-93-2

Basic information

• Product Name: N-T-BUTYLGLYCINE SODIUM SALT
• Synonyms: N-T-BUTYLGLYCINE SODIUM SALT;N-TERT-BUTYLGLYCINE SODIUM SALT;N-t-Butyl Glycine;N-tert-Butylglycine;N-(1,1-Dimethylethyl)-glycine
• CAS NO: 58482-93-2
• Molecular Formula: C₆H₁₃NO₂
• Molecular Weight: 153.15
• Product Categories: pharmacetical
• Mol File: 58482-93-2.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 206.9°Cat760mmHg
• Flash Point: 78.9°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 0.0935mmHg at 25°C
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 2.37±0.10(Predicted)
• CAS DataBase Reference: N-T-BUTYLGLYCINE SODIUM SALT(CAS DataBase Reference)
• NIST Chemistry Reference: N-T-BUTYLGLYCINE SODIUM SALT(58482-93-2)
• EPA Substance Registry System: N-T-BUTYLGLYCINE SODIUM SALT(58482-93-2)

Safety Data

• Hazardous Substances Data: 58482-93-2(Hazardous Substances Data)

Usage

General Description

N-t-butylglycine sodium salt is a chemical compound that is derived from the amino acid glycine. It is commonly used as an intermediate in organic synthesis and pharmaceutical manufacturing. N-T-BUTYLGLYCINE SODIUM SALT is known for its ability to act as a buffer, controlling the pH of a solution when added in small amounts. It is also used as a chiral selector in chromatography and as a building block in the production of various pharmaceutical products. Additionally, N-t-butylglycine sodium salt has been studied for its potential use as a therapeutic agent for treating various diseases and disorders. Overall, this chemical compound has a wide range of applications in the fields of chemistry, pharmaceuticals, and medicine.

InChI:InChI=1/C6H13NO2.Na/c1-6(2,3)7-4-5(8)9;/h7H,4H2,1-3H3,(H,8,9);/q;+1/p-1

Upstream product

• 105-36-2 ethyl bromoacetate 
• 75-64-9 tert-butylamine 
• 107-16-4 glycolonitrile 
• 2504-18-9 tert-butyl-methyl-nitroso-amine 
• 14610-37-8 N-methyl-tert-butylamine 
• 37885-76-0 ethyl 2-(tert-butylamino)acetate 
• 6939-24-8 N-nitroso-N-(t-butyl)glycine 
• 762-84-5 N-tert-butylacetamide 

Downstream Products

• 6939-24-8 N-nitroso-N-(t-butyl)glycine 
• 220620-09-7 tigecycline 
• 85916-13-8 tert-butyl iminodiacetate 
• 1310682-49-5 N-(tert-butoxycarbonyl)-N'-(3,4-dichlorophenyl)-N''-(1-tert-butyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)guanidine 
• 1310682-46-2 N-(3,4-dichlorophenyl)-N'-(1-tert-butyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)guanidine 
• 62965-35-9 N-tert-butyloxycarbonyl-L-tert-leucine 
• 6939-25-9 3-(t-butyl)sydnone 

Relevant articles and documents

2-GUANIDINO-4-OXO-IMIDAZOLINE DERIVATIVES AS ANTIMALARIAL AGENTS, SYNTHESIS AND METHODS OF USE THEREOF

The present invention relates to new 2-guanidino-4-oxo-imidazoline derivatives (deoxo-IZ), methods of making these compounds, compositions containing the same, and methods of using the same to prevent, treat, or inhibit malaria in a subject.

PROCESS FOR PRODUCTION OF PYRROLIDINE COMPOUNDS

A process for the production of compounds represented by the general formula (3) or salts thereof: (3) which comprises reacting a compound represented by the general formula (1): (1) with a compound represented by the general formula (2) or a salt thereof

Process for producing beta-1, 3-n-acetylglucosamine transferase and n-acetylglucosamine- containing composite saccharide

The present invention can provide a process for producing a protein having β1,3-N-acetylglucosaminyltransferase activity using a transformant comprising a DNA encoding a protein having β1,3-N-acetylglucosaminyltransferase activity derived from a microorganism belonging to the genus Pasteurella and a process for producing an N-acetylglucosamine-containing complex carbohydrate using a transformant capable of producing a protein having β1,3-N-acetylglucosaminyltransferase activity derived from a microorganism.